English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 90533/120562 (75%)
Visitors : 24965270      Online Users : 325
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://nccur.lib.nccu.edu.tw/handle/140.119/122269

    Title: 新藥進入台灣健保市場准入委外顧問業商機與發展策略之探討 – 以A公司為例
    The Study of Business Opportunities and Development Strategies of the Consultant for Pharmaceutical Market Access
    Authors: 廖永良
    Liao, Yung-Liang
    Contributors: 李易諭
    Lee, Yih-Yuh
    Liao, Yung-Liang
    Keywords: 新藥
    New drug
    Market access
    Out sourcing
    Date: 2019
    Issue Date: 2019-02-12 15:43:46 (UTC+8)
    Abstract: 委外服務可為公司帶來節省人力、降低營運成本、提升績效等益處,在各行各業極為平常。新藥進入台灣健保市場准入是一個新興的工作領域,委外服務更是此新興工作領域所衍生的新商機。本研究目的探討藥廠委外的內部決策關鍵因素,以及委外服務業影響藥廠委託案件的公司本質,經由質化與量化資料的收集與分析,來提供個案公司未來營運與發展策略建議。


    Data show that outsourcing service could decrease the inner manpower, save the operation cost and increase performance. It is general for of a company in different field to outsource a job. The new drug access to NHI market is a new developed job field and the outsourcing service of new drug access to NHI market is as new developed business opportunity. The purpose of this study is going to know the key decision factor for the pharmaceutical company outsourcing new drug access job. Furthermore, it is going to know which profile of service providers influence the pharmaceutical company’s outsourcing decision. Both qualitative and quantitative data are collected and analyzed for advising future strategic development for case company

    This is a case study research, inviting the market access staff from the pharmaceuticals and case company for focus group interviews respectively. The final analysis showed that there were 13 key items influencing pharmaceutical companies to outsource new drug access to NHI market. The greatest factor was “increase the capability of pricing strategy (weight value: 0.151).” Interestingly, it was also the most important item which the case company could satisfied with the pharmaceutical company’s need (difference of weight grade: 0.604). The case company was only inferior to the competitor in the items of “import technologic skills e.g. health economics & outcomes research and budget impact” and “assist in communicating with head office. “There were 10 profile items of service provider influencing the pharmaceutical company’s outsourcing decision. The greatest factor was “local market access experience of the service provider (weight value: 0.150).” Interestingly, it was also the most important item which the case company could satisfied with the pharmaceutical company’s need (difference of weight grade: 0.750). The case company was inferior to the competitor in all 3 items of company resource related dimension and in the item of “non-professional but beneficial behavior” of market related dimension.

    The study results referred to the original strengths of the case company which were professional capability and abundant work experience of human resources. The strengths of international competitors were resources support from head office and non-professional but beneficial behavior of market dimension. Suggest the case company maintain or increase the power of human resources and further keep collaboration with local or foreign alliances. Therefore, good use of outside resources for supplementing inner deficiency will be the quickest way to grow and increase competitive advantages.
    Reference: 一、中文文獻
    方博亮、林祖嘉(2017)。管理經濟學(五版) 。台北:智勝文化。
    吳安妮、劉俊儒 (2001)。員工面、內部營運面,及顧客面對財務績效影響之實證研究。台灣管理學刊 1(1),125-150。
    陳志豪、張可臻 & 林忠順(2012)。全民健保單一保險制度的優缺點。家庭醫學與基層醫療,27(6),222-225。
    陳昭姿(2014)。歷年健保新藥管理趨勢回顧。衛生福利部醫療爭議審議報導系列53 特刊。
    瑞姆.夏藍(2005)。CEO要你知道的事(胡瑋珊譯)。台北:天下文化 (原著出版年:2001)

    Gereffi, G., & Fernandez-Stark, K. (2016). Global value chain analysis: A primer. Duke CGGC.
    Ghodeswar, B., & Vaidyanathan, J. (2008). Business process outsourcing: An approach to gain access to world-class capabilities. Business Process Management Journal, 14(1), 23-38.
    Hwang, C. L., & Yoon, K. (1981). Methods for multiple attribute decision making. In Multiple attribute decision making (pp. 58-191). Springer, Berlin.
    Possnert, M., Svensson, M., & Ecarla, F. (2009). Managing the fourth hurdle. Uppsala Universitet.
    Sendyona, S. (2014). A payer’s perspective to pharmaceutical market access: Defining market access. Value in Health, 17(7), A428.
    Sendyona, S., Odeyemi, I., & Maman, K. (2016). Perceptions and factors affecting pharmaceutical market access: Results from a literature review and survey of stakeholders in different settings. Journal of Market Access & Health Policy, 4(1), 31660., Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040822/pdf/JMAHP-4-31660.pdf
    Sobrio A, Boggio F. (2011), “Have you optimized your Market Access Efforts?” Pharmaceutical Executive Global Digest. Chester, UK: Advanstar Communications (U.K.) Ltd.

    Health technology assessment, Retrieved October, 9, 2018, WHO, from http://www.who.int/health-technology-assessment/en/
    Description: 碩士
    Source URI: http://thesis.lib.nccu.edu.tw/record/#G0105932182
    Data Type: thesis
    DOI: 10.6814/THE.NCCU.EMBA.021.2019.F08
    Appears in Collections:[經營管理碩士學程EMBA] 學位論文

    Files in This Item:

    File SizeFormat
    218201.pdf6431KbAdobe PDF0View/Open

    All items in 政大典藏 are protected by copyright, with all rights reserved.

    社群 sharing

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback